HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 23 filers reported holding HEMISPHERX BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,000 | -64.3% | 39,275 | -62.8% | 0.00% | – |
| Q1 2016 | $14,000 | +55.6% | 105,564 | -4.3% | 0.00% | – |
| Q4 2015 | $9,000 | -52.6% | 110,268 | -2.0% | 0.00% | – |
| Q3 2015 | $19,000 | -26.9% | 112,567 | -8.1% | 0.00% | – |
| Q2 2015 | $26,000 | +420.0% | 122,548 | +454.3% | 0.00% | – |
| Q1 2015 | $5,000 | 0.0% | 22,110 | +9.9% | 0.00% | – |
| Q4 2014 | $5,000 | – | 20,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 190,000 | $521,000 | 0.65% |
| WEDBUSH SECURITIES INC | 80,000 | $18,000 | 0.00% |
| CITY HOLDING CO | 5,000 | $1,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 290,000 | $66,120,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 20,792 | $4,000 | 0.00% |
| NORTHERN TRUST CORP | 235,051 | $53,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 897,977 | $204,000 | 0.00% |
| STATE STREET CORP | 81,000 | $18,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 37,501 | $9,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 24,735 | $6,000 | 0.00% |